OrthoPediatrics Corp. (KIDS)
Largest Insider Buys in Sector
KIDS Stock Price History Chart
KIDS Stock Performance
About OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking …
Insider Activity of OrthoPediatrics Corp.
Over the last 12 months, insiders at OrthoPediatrics Corp. have bought $0 and sold $770,375 worth of OrthoPediatrics Corp. stock.
On average, over the past 5 years, insiders at OrthoPediatrics Corp. have bought $426,413 and sold $3.54M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,235 shares for transaction amount of $48,721 was made by Ruf Harold () on 2022‑06‑16.
List of Insider Buy and Sell Transactions, OrthoPediatrics Corp.
| 2024-08-21 | Sale | General Counsel and Secretary | 10,000 0.0385% | $29.30 | $293,000 | -12.98% | ||
| 2024-03-11 | Sale | President and CEO | 3,213 0.0137% | $27.59 | $88,647 | +7.26% | ||
| 2024-03-11 | Sale | director | 2,433 0.0104% | $27.59 | $67,126 | +7.26% | ||
| 2024-03-11 | Sale | COO and CFO | 3,195 0.0136% | $27.59 | $88,150 | +7.26% | ||
| 2024-03-11 | Sale | President of Scoliosis | 2,768 0.0118% | $27.59 | $76,369 | +7.26% | ||
| 2024-03-11 | Sale | General Counsel and Secretary | 2,741 0.0117% | $27.59 | $75,624 | +7.26% | ||
| 2024-02-22 | Sale | Pres. Trauma & Def. Correction | 2,903 0.0123% | $28.06 | $81,458 | +3.60% | ||
| 2023-08-11 | Sale | director | 2,610 0.0111% | $38.25 | $99,833 | -22.38% | ||
| 2023-06-26 | Sale | COO and CFO | 4,356 0.0196% | $43.69 | $190,304 | -28.69% | ||
| 2023-04-27 | Sale | President of Scoliosis | 3,333 0.0146% | $50.10 | $166,969 | -37.86% | ||
| 2023-04-25 | Sale | President of Scoliosis | 828 0.0037% | $50.02 | $41,420 | -36.26% | ||
| 2023-04-21 | Sale | President of Scoliosis | 644 0.0029% | $50.02 | $32,212 | -35.62% | ||
| 2023-03-06 | Sale | director | 4,515 0.0199% | $43.83 | $197,872 | -17.67% | ||
| 2023-03-06 | Sale | President and CEO | 4,052 0.0181% | $44.40 | $179,910 | -17.67% | ||
| 2023-03-06 | Sale | COO and CFO | 4,099 0.0181% | $43.77 | $179,397 | -17.67% | ||
| 2023-03-06 | Sale | Executive Vice President | 3,421 0.0152% | $44.03 | $150,618 | -17.67% | ||
| 2023-03-06 | Sale | General Counsel and Secretary | 3,315 0.0149% | $44.62 | $147,916 | -17.67% | ||
| 2023-03-02 | Sale | Sr VP & GM Trauma & Deformity | 2,554 0.0115% | $43.74 | $111,705 | -14.85% | ||
| 2023-02-02 | Sale | Executive Vice President | 1,195 0.0053% | $50.00 | $59,754 | -20.21% | ||
| 2023-01-20 | Sale | Executive Vice President | 80 0.0004% | $47.00 | $3,760 | -11.86% |
Insider Historical Profitability
| Berry Bernie B III | director | 23481 0.097% | $26.47 | 1 | 13 | +70.71% |
| Pelizzon David R | director | 23125 0.0955% | $26.47 | 5 | 0 | +31.39% |
| Ruf Harold | 13824 0.0571% | $26.47 | 3 | 0 | +18.58% | |
| Pritzker Jennifer N. | 10 percent owner | 707 0.0029% | $26.47 | 7 | 0 | <0.0001% |
Institutional Investor Ownership
| Brown Capital Management | $81.41M | 11.72 | 2.79M | -15.87% | -$15.35M | 1.45 | |
| Brown Advisory | $48.07M | 6.92 | 1.65M | +1.21% | +$573,256.46 | 0.06 | |
| BlackRock | $35.5M | 5.11 | 1.22M | +1.45% | +$508,171.31 | <0.01 | |
| Braidwell Lp | $32.3M | 4.65 | 1.11M | 0% | +$0 | 1.83 | |
| The Vanguard Group | $25.77M | 3.71 | 883,827 | +1.27% | +$323,676.01 | <0.0001 |